Embla Medical hf. (FRA:5IQ)

Market Cap	1.72B -5.9%
Revenue (ttm)	861.69M +12.7%
Net Income	82.23M +28.5%
EPS	0.19 +27.2%
Shares Out	n/a
PE Ratio	20.89
Forward PE	18.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	3.935
Previous Close	3.950
Day's Range	3.935 - 3.935
52-Week Range	3.370 - 5.040
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides os...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1971
• Employees: 4,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5IQ

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error